[1]
|
Tang, W.H.W., Li, D.Y. and Hazen, S.L. (2018) Dietary Metabolism, the Gut Microbiome, and Heart Failure. Nature Reviews Cardiology, 16, 137-154. https://doi.org/10.1038/s41569-018-0108-7
|
[2]
|
刘月姣. 《中国居民营养与慢性病状况报告(2020年)》发布[J]. 中国食物与营养, 2020, 26(12): 2.
|
[3]
|
谢果珍, 黄莉莉, 张水寒, 等. 肠道微生物代谢苷类化合物的研究进展[J]. 天然产物研究与开发, 2022, 34(7): 1261-1271.
|
[4]
|
毕玉晶, 杨瑞馥. 人体肠道微生物群、营养与健康[J]. 科学通报, 2019, 64(3): 260-271.
|
[5]
|
Oussaada, S.M., van Galen, K.A., Cooiman, M.I., Kleinendorst, L., Hazebroek, E.J., van Haelst, M.M., et al. (2019) The Pathogenesis of Obesity. Metabolism, 92, 26-36. https://doi.org/10.1016/j.metabol.2018.12.012
|
[6]
|
La Sala, M.S., Hurtado, M.D., Brown, A.R., Bohórquez, D.V., Liddle, R.A., Herzog, H., et al. (2013) Modulation of Taste Responsiveness by the Satiation Hormone Peptide YY. The FASEB Journal, 27, 5022-5033. https://doi.org/10.1096/fj.13-228064
|
[7]
|
Swartz, T.D., Duca, F.A., de Wouters, T., Sakar, Y. and Covasa, M. (2011) Up-Regulation of Intestinal Type 1 Taste Receptor 3 and Sodium Glucose Luminal Transporter-1 Expression and Increased Sucrose Intake in Mice Lacking Gut Microbiota. British Journal of Nutrition, 107, 621-630. https://doi.org/10.1017/s0007114511003412
|
[8]
|
王珊珊, 韩永和, 李敏. 饮食和肠道微生物对肥胖的代谢调控作用与机制[J]. 生命的化学, 2021, 41(3): 541-551.
|
[9]
|
Perry, R.J., Peng, L., Barry, N.A., Cline, G.W., Zhang, D., Cardone, R.L., et al. (2016) Acetate Mediates a Microbiome-Brain-β-Cell Axis to Promote Metabolic Syndrome. Nature, 534, 213-217. https://doi.org/10.1038/nature18309
|
[10]
|
Brial, F., Alzaid, F., Sonomura, K., Kamatani, Y., Meneyrol, K., Le Lay, A., et al. (2020) The Natural Metabolite 4-Cresol Improves Glucose Homeostasis and Enhances β-Cell Function. Cell Reports, 30, 2306-2320. https://doi.org/10.1016/j.celrep.2020.01.066
|
[11]
|
Hoyles, L., Fernández-Real, J.-M., Federici, M., Serino, M., Abbott, J., Charpentier, J., et al. (2018) Molecular Phenomics and Metagenomics of Hepatic Steatosis in Non-Diabetic Obese Women. Nature Medicine, 24, 1070-1080. https://doi.org/10.1038/s41591-018-0061-3
|
[12]
|
de Mello, V.D., Paananen, J., Lindström, J., Lankinen, M.A., Shi, L., Kuusisto, J., et al. (2017) Indolepropionic Acid and Novel Lipid Metabolites Are Associated with a Lower Risk of Type 2 Diabetes in the Finnish Diabetes Prevention Study. Scientific Reports, 7, Article No. 46337. https://doi.org/10.1038/srep46337
|
[13]
|
Koh, A., Molinaro, A., Ståhlman, M., Khan, M.T., Schmidt, C., Mannerås-Holm, L., et al. (2018) Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1. Cell, 175, 947-961. https://doi.org/10.1016/j.cell.2018.09.055
|
[14]
|
MacDonald, M.J., Fahien, L.A., Mertz, R.J. and Rana, R.S. (1989) Effect of Esters of Succinic Acid and Other Citric Acid Cycle Intermediates on Insulin Release and Inositol Phosphate Formation by Pancreatic Islets. Archives of Biochemistry and Biophysics, 269, 400-406. https://doi.org/10.1016/0003-9861(89)90123-9
|
[15]
|
Wang, Z., Chen, Z., Zhang, L., Wang, X., Hao, G., Zhang, Z., et al. (2018) Status of Hypertension in China: Results from the China Hypertension Survey, 2012-2015. Circulation, 137, 2344-2356. https://doi.org/10.1161/circulationaha.117.032380
|
[16]
|
GBD 2017 DALYs and HALE Collaborators (2018) Global, Regional, and National Disability-Adjusted Life-Years (DALYs) for 359 Diseases and Injuries and Healthy Life Expectancy (HALE) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 392, 1859-1922. https://doi.org/10.1016/S0140-6736(18)32335-3
|
[17]
|
陈冬梅. 空气污染物暴露对高血压大鼠肠道微生物群和心肌组织的影响及机制探讨[D]: [博士学位论文]. 长春: 吉林大学, 2021.
|
[18]
|
Wang, T., Gao, H., He, C., Gao, L., Wang, B., Hua, R., et al. (2023) Adult Hypertensive Rats Are More Prone to Gut Microflora Perturbation and Fibrosis in Response to Moderate Restraint Stress. Translational Research, 254, 92-114. https://doi.org/10.1016/j.trsl.2022.10.006
|
[19]
|
Lu, D., Xu, S., Dai, P., Wu, L., Zhang, H. and Zhou, B. (2022) Gut Microbiota in Hypertensive Patients with versus without Obstructive Sleep Apnea. The Journal of Clinical Hypertension, 24, 1598-1605. https://doi.org/10.1111/jch.14598
|
[20]
|
Avery, E.G., Bartolomaeus, H., Rauch, A., Chen, C.-Y., N’Diaye, G., Löber, U., et al. (2022) Quantifying the Impact of Gut Microbiota on Inflammation and Hypertensive Organ Damage. Cardiovascular Research, 119, 1441-1452. https://doi.org/10.1093/cvr/cvac121
|
[21]
|
Romano, K.A., Nemet, I., Prasad Saha, P., Haghikia, A., Li, X.S., Mohan, M.L., et al. (2023) Gut Microbiota-Generated Phenylacetylglutamine and Heart Failure. Circulation: Heart Failure, 16, e009972. https://doi.org/10.1161/circheartfailure.122.009972
|
[22]
|
蔡斌, 张振东, 王宏伟. 肠道微生物及其代谢产物与心力衰竭相关性研究[J]. 贵州医药, 2022, 46(7): 1014-1016.
|